calendar
7,774 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
7,774 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 2.01, 2.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01
Items: 3.01, 3.03, 5.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 8.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 8.01
Items: 5.02
Items: 5.02, 9.01
Items: 5.02, 5.03, 5.07, 9.01
Items: 2.01, 8.01, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 1.01, 3.03, 8.01, 9.01
Items: 2.02
Items: 5.07
Items: 7.01, 9.01
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Gastrointestinal, Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma), Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, Metastatic Liver Cancer
Therapy area: Central Nervous System. Indication: Unspecified Pain
Therapy area: Cardiovascular. Indication: Hypertension
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Undisclosed. Indication: Unspecified
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Central Nervous System, Dermatology, Ear Nose Throat Disorders, Gastrointestinal, Genito Urinary System, Infectious Disease, Mouth and Dental Disorders, Respiratory. Indication: Abscess, Acne Vulgaris, Acute Bacterial Sinusitis, Acute Bronchitis, Acute Pharyngitis, Bacterial Pneumonia, Bacterial Respiratory Tract Infections, Bartonella Infections, Bronchitis, Carbuncle, Cellulitis, Chlamydia trachomatis Pneumonia, Chronic Bronchitis, Community Acquired Pneumonia, Community-Acquired
Therapy area: Cardiovascular, Metabolic Disorders. Indication: Congestive Heart Failure (Heart Failure), Type 2 Diabetes
Therapy area: Immunology. Indication: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Therapy area: Immunology. Indication: Autoimmune Disorders, Diffuse Cutaneous Systemic Sclerosis, Systemic Sclerosis (Scleroderma)
Therapy area: Metabolic Disorders, Musculoskeletal Disorders. Indication: Gouty Arthritis (Gout), Hyperuricemia
Therapy area: Dermatology. Indication: Burns
Therapy area: Metabolic Disorders. Indication: Obesity, Overweight
Therapy area: Central Nervous System. Indication: Parkinson's Disease
Therapy area: Musculoskeletal Disorders. Indication: Psoriatic Arthritis
Therapy area: Hormonal Disorders. Indication: Endocrine Gland Disorders
Therapy area: Immunology, Mouth and Dental Disorders. Indication: Inflammation, Periodontal Disease, Periodontitis
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Central Nervous System, Gastrointestinal. Indication: Inguinal Hernia, Post-Operative Pain
Therapy area: Gastrointestinal. Indication: Metabolic and Alcohol-Associated Liver Disease (MetALD), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)